Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Shenzhen Salubris Pharmaceuticals Co., Ltd.
—
Shenzhen Salubris Pharmaceuticals Co., Ltd. is led by CEO Jie Yan, employs 4,087 people, headquartered in Shenzhen, CN, publicly traded since 2009.
Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) stock trades at $30.79 with a market capitalization of $34.57B. The stock is valued at a price-to-earnings (P/E) ratio of 51.68, price-to-book of 4.02, price-to-sales of 7.35. Over the past 52 weeks the stock has ranged between $29.25 and $70.99, and currently trades 56.6% below its 52-week high. It pays a dividend yielding 1.76%.
On profitability, Shenzhen Salubris Pharmaceuticals Co., Ltd. generates a return on equity (ROE) of 7.68%, an operating margin of 12.66%, a net profit margin of 14.33%.
The balance sheet shows a debt-to-equity ratio of 0.05 (debt below half of shareholders' equity), a current ratio of 2.03.
002294.SZ has an average daily trading volume of 29,293,298 shares, a beta of -0.16, 1.11B shares outstanding.
Official website: www.salubris.com
Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) — frequently asked questions
What is Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) stock price today?
Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) is currently trading at $30.79, down 3.12% today.
What is 002294.SZ P/E ratio?
Shenzhen Salubris Pharmaceuticals Co., Ltd.'s P/E ratio is 51.68. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.
What is 002294.SZ return on equity (ROE)?
Shenzhen Salubris Pharmaceuticals Co., Ltd.'s return on equity (ROE) is 7.68%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is Shenzhen Salubris Pharmaceuticals Co., Ltd.'s market cap?
Shenzhen Salubris Pharmaceuticals Co., Ltd. has a market capitalization of $34.57B.
Does 002294.SZ pay a dividend?
Yes. Shenzhen Salubris Pharmaceuticals Co., Ltd. currently yields 1.76%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 002294.SZ carry?
Shenzhen Salubris Pharmaceuticals Co., Ltd. has a debt-to-equity ratio of 0.05. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 002294.SZ's profit margin?
Shenzhen Salubris Pharmaceuticals Co., Ltd. reports a net profit margin of 14.33% — the share of revenue left after every cost, including tax and interest.
What sector is 002294.SZ in?
Shenzhen Salubris Pharmaceuticals Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 002294.SZ listed on?
Shenzhen Salubris Pharmaceuticals Co., Ltd. trades on SHZ under the ticker 002294.SZ.
What is 002294.SZ's 52-week range?
Over the last year Shenzhen Salubris Pharmaceuticals Co., Ltd. has traded between $29.25 and $70.99.
Related — Stocks
Popular Stocks
Screens 002294.SZ currently matches
On the figures above, Shenzhen Salubris Pharmaceuticals Co., Ltd. passes the filters for 12 of our ready-made screens, among them Dividend Stocks, S&P 500 Dividend Stocks, Low Debt Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.